Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity
Immunity, Inflammation and Disease · 2025
DOI: 10.1002/iid3.70143 ↗Kurz gefasst
Fachartikel in der Zeitschrift Immunity, Inflammation and Disease, 2025. Verfasst von Jun Zhou und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Clinical Medical College of Fujian Medical U…. Hauptthemen laut MEDLINE: Melanoma, Killer Cells, Natural, Skin Neoplasms. Die Arbeit nennt 23 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Skin melanoma exhibits significant heterogeneity in clinical outcomes and treatment responses among patients. This study aimed to investigate natural killer (NK) cell clusters in skin melanoma, their impact on patient prognosis, and their value as biomarkers for tailoring treatment.
Methods
We used data from TCGA, GSE19234, GSE65904, GSE244982, and GSE78220. A gene classifier was developed to identify two distinct clusters of melanoma patients. Survival analysis, NK cell infiltration levels, and responses to immune and targeted therapies were evaluated.
Results
Unsupervised clustering revealed two distinct melanoma patient clusters with significant differences in NK cell activity and clinical outcomes. Cluster 1 showed higher NK cell infiltration, better overall survival (OS) ( p < 0.0001), and greater activity in NK‐cell‐related pathways. In contrast, Cluster 2, characterized by lower NK cell activity and higher exhaustion markers, had poorer OS. Drug sensitivity analysis indicated that Cluster 1 was more responsive to most melanoma treatments, whereas Cluster 2 had higher sensitivity to trametinib ( p < 0.001). The developed gene classifier had an AUC of 0.913 and effectively differentiated between clusters. Additionally, Cluster 1 showed better responses to immunotherapy with a higher rate of complete and partial responses ( p < 0.001). These findings were validated in external databases.
Conclusion
This study identifies two distinct NK‐cell‐related clusters in melanoma with differential prognoses and treatment responses. These findings underscore the importance of integrating NK‐cell‐related profiles into personalized treatment strategies, offering a pathway to optimize therapeutic outcomes based on specific immune profiles.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Dermatology, Fuzhou University Affiliated Provincial Hospital, Fujian Provincial Hospital, Clinical Medical College of Fujian Medical University, Fuzhou, China.
ORCID-Profile: Jun Zhou
Zitieren
APA
Zhou, J., Cai, R., Zhang, D., & Chen, C. (2025). Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity. Immunity, Inflammation and Disease. https://doi.org/10.1002/iid3.70143
Vancouver
Zhou J, Cai R, Zhang D, Chen C. Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity. Immunity, Inflammation and Disease. 2025. doi:10.1002/iid3.70143
BibTeX
@article{Zhou2025,
author = {Zhou, Jun and Cai, Renhui and Zhang, Danqun and Chen, Caifeng},
title = {Identification of Natural Killer Cell‐Associated Clusters in Skin Melanoma and the Impact on Prognosis and Drug Sensitivity},
journal = {Immunity, Inflammation and Disease},
year = {2025},
doi = {10.1002/iid3.70143}
}
EUVIMED